Patents by Inventor Magdalena Renke-gluszko

Magdalena Renke-gluszko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10596303
    Abstract: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: March 24, 2020
    Assignee: Invatec Technology Center GMBH
    Inventors: Ulrich Speck, Silvio Schaffner, Magdalena Renke-Gluszko
  • Publication number: 20190015562
    Abstract: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.
    Type: Application
    Filed: July 23, 2018
    Publication date: January 17, 2019
    Inventors: Ulrich Speck, Silvio Schaffner, Magdalena Renke-Gluszko
  • Patent number: 10029032
    Abstract: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: July 24, 2018
    Assignee: Invatec Technology Center GMBH
    Inventors: Ulrich Speck, Silvio Schaffner, Magdalena Renke-Gluszko
  • Publication number: 20170173220
    Abstract: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.
    Type: Application
    Filed: February 23, 2017
    Publication date: June 22, 2017
    Inventors: Ulrich SPECK, Silvio SCHAFFNER, Magdalena RENKE-GLUSZKO
  • Publication number: 20110295200
    Abstract: The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.
    Type: Application
    Filed: January 8, 2010
    Publication date: December 1, 2011
    Inventors: Ulrich Speck, Silvio Schaffner, Magdalena Renke-gluszko